Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousTransplantation ConditioningGraft vs Host DiseaseHematologic NeoplasmsStem Cell TransplantationHematopoietic Stem Cell MobilizationHematopoietic Stem CellsCombined Modality TherapyMelphalanMyeloablative AgonistsAntigens, CD34Granulocyte Colony-Stimulating FactorBusulfanTreatment OutcomeLeukapheresisBone Marrow TransplantationMultiple MyelomaGraft SurvivalCyclophosphamideBlood Component RemovalTransplantation ChimeraRecurrenceAntineoplastic Combined Chemotherapy ProtocolsTissue DonorsRemission InductionGraft vs Leukemia EffectStem CellsLeukocytes, MononuclearRetrospective StudiesLymphoma, Non-HodgkinCord Blood Stem Cell TransplantationWhole-Body IrradiationHistocompatibilityHistocompatibility TestingSalvage TherapyLeukemiaEtoposideThiotepaHematopoiesisAntineoplastic Agents, AlkylatingDisease-Free SurvivalVidarabineSurvival RateTime FactorsLeukemia, Myeloid, AcuteImmunosuppressive AgentsSurvival AnalysisGraft vs Tumor EffectCytarabineCarmustineHematologic DiseasesMyelodysplastic SyndromesChimerismCytomegalovirus InfectionsT-LymphocytesCytophagocytosisTransplantation, IsogeneicHLA AntigensVincristineIfosfamideHodgkin DiseaseNeoplasmsAmyloidosisFollow-Up StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphocyte TransfusionFlow CytometrySiblingsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveAnemia, AplasticLymphocyte DepletionAllograftsInfectionOpportunistic InfectionsAcute DiseaseFatal OutcomeTransplantation ImmunologyHepatic Veno-Occlusive DiseaseAntineoplastic AgentsLiver TransplantationProspective StudiesCells, CulturedLymphoma, T-CellBlood CellsPlatelet CountNeoplasm, ResidualImmunophenotypingDoxorubicinBlood Cell CountPrognosisImmunosuppressionBone Marrow CellsRecombinant ProteinsPrednisoneBone MarrowPOEMS SyndromeLymphoma